SofWave Medical Ltd. (TLV:SOFW)
Israel · Delayed Price · Currency is ILS · Price in ILA 3,799.00
-84.00 (-2.16%)
Aug 7, 2026, 1:44 PM IDT
SofWave Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 104.35 | 87.64 | 59.65 | 50.32 | 35.63 | 21.84 | |
Revenue Growth | 50.17% | 46.92% | 18.55% | 41.22% | 63.15% | 408.95% |
Cost of Revenue | 25.75 | 21.68 | 14.32 | 12.83 | 9.3 | 5.63 |
Gross Profit | 78.6 | 65.96 | 45.34 | 37.48 | 26.33 | 16.21 |
Selling, General & Admin | 53.87 | 46.29 | 38.15 | 34.04 | 31.23 | 17 |
Research & Development | 14.6 | 12.8 | 10.77 | 11.43 | 12.44 | 8.21 |
Other Operating Expenses | - | - | - | - | -0 | - |
Operating Expenses | 68.47 | 59.09 | 48.92 | 45.47 | 43.67 | 25.21 |
Operating Income | 10.13 | 6.87 | -3.58 | -7.99 | -17.34 | -9 |
Interest Expense | -0.15 | -0.07 | -0.06 | -0.06 | -0.19 | -0.11 |
Interest & Investment Income | 0.67 | 0.67 | 0.7 | 0.78 | 0.33 | 0.03 |
Currency Exchange Gain (Loss) | 0.05 | 0.05 | 0.01 | 0.02 | -1.07 | 2.26 |
Other Non Operating Income (Expenses) | -1.49 | -1.79 | -1.13 | -1 | -0.94 | -0.46 |
EBT Excluding Unusual Items | 9.21 | 5.74 | -4.06 | -8.26 | -19.21 | -7.28 |
Other Unusual Items | - | - | - | - | - | 0.14 |
Pretax Income | 9.21 | 5.74 | -4.06 | -8.26 | -19.21 | -7.15 |
Income Tax Expense | 0.35 | 0.25 | 0.49 | 0.02 | 0.32 | -0.32 |
Net Income | 8.85 | 5.49 | -4.55 | -8.28 | -19.53 | -6.83 |
Net Income to Common | 8.85 | 5.49 | -4.55 | -8.28 | -19.53 | -6.83 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 36 | 35 | 34 | 34 | 34 | 23 |
Shares Outstanding (Diluted) | 40 | 40 | 34 | 34 | 34 | 23 |
Shares Change | 15.79% | 15.83% | 0.53% | 0.26% | 44.98% | -45.50% |
EPS (Basic) | 0.25 | 0.15 | -0.13 | -0.24 | -0.57 | -0.29 |
EPS (Diluted) | 0.22 | 0.14 | -0.13 | -0.24 | -0.57 | -0.29 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 13.07 | 12.76 | -2.67 | -6.71 | -11.14 | -5.22 |
Free Cash Flow Per Share | 0.33 | 0.32 | -0.08 | -0.20 | -0.33 | -0.22 |
Gross Margin | 75.33% | 75.27% | 76.00% | 74.49% | 73.90% | 74.21% |
Operating Margin | 9.70% | 7.84% | -6.00% | -15.88% | -48.66% | -41.22% |
Profit Margin | 8.48% | 6.26% | -7.62% | -16.45% | -54.81% | -31.26% |
Free Cash Flow Margin | 12.53% | 14.56% | -4.48% | -13.34% | -31.27% | -23.90% |
EBITDA | 11.44 | 7.91 | -2.22 | -6.49 | -16.22 | -8.87 |
EBITDA Margin | 10.96% | 9.03% | -3.73% | -12.89% | -45.52% | -40.62% |
D&A For EBITDA | 1.31 | 1.04 | 1.36 | 1.51 | 1.12 | 0.13 |
EBIT | 10.13 | 6.87 | -3.58 | -7.99 | -17.34 | -9 |
EBIT Margin | 9.70% | 7.84% | -6.00% | -15.88% | -48.66% | -41.22% |
Effective Tax Rate | 3.83% | 4.34% | - | - | - | - |
Advertising Expenses | - | 8.4 | 8.23 | 4.68 | 3.85 | 1.45 |